Paradigm Biopharmaceuticals | PAR - Current Liabilities

Stock Price
0.27
Daily Change
-0.002 -0.74%
Monthly
-17.54%
Yearly
-55.33%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD3.23M in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Avita Medical AUD 62.6M 42.44M Jun/2025
Medical Developments International AUD 7.82M 1.45M Jun/2025
Neuren Pharmaceuticals AUD 7.92M 37.84M Jun/2025
Pacific Edge NZD 7.22M 2.54M Dec/2025
PYC Therapeutics AUD 12.32M 939.58K Jun/2025
Telix Pharmaceuticals AUD 231.62M 66.96M Dec/2025